Shopping Cart

Your shopping cart is currently empty

MKI-1 (Synonyms: MASTL Kinase Inhibitor-1)

Name: MKI-1
Brand: TargetMol
SKU: T60688
Price: 61 USD
Availability: InStock
Rating: 5 (10 reviews)

Catalog No. T60688 Copy Product Info

Purity: 99.81%

🥰Excellent

MKI-1 (MASTL Kinase Inhibitor-1) is an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like, IC50= 9.9 μM). MKI-1 exerts radiosensitizer and antitumor activities through PP2A activation in breast cancer.

MKI-1

Copy Product Info

🥰Excellent

Catalog No. T60688

Synonyms MASTL Kinase Inhibitor-1

Cas No. 1190277-80-5

Customer service consultation

Pack Size	Price	USA Stock	Global Stock
1 mg	$61	In Stock	In Stock
2 mg	$88	In Stock	In Stock
5 mg	$147	In Stock	In Stock
10 mg	$222	In Stock	In Stock
25 mg	$357	In Stock	In Stock
50 mg	$490	In Stock	In Stock
100 mg	$689	In Stock	In Stock
200 mg	$978	-	In Stock
1 mL x 10 mM (in DMSO)	$162	In Stock	In Stock

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Purity:99.81%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	MKI-1 (MASTL Kinase Inhibitor-1) is an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like, IC50= 9.9 μM). MKI-1 exerts radiosensitizer and antitumor activities through PP2A activation in breast cancer.
Targets&IC50	MASTL:9.9 μM
In vitro	MKI-1 (20 μM, 16 h) reduces c-Myc stability through PP2A activation in MCF7 cells. MKI-1 (5-20 μM) inhibits the activity of MASTL in breast cancer cells. MKI-1 (100 μM, 72 h) inhibits various oncogenic properties of breast cancer cells but showed much weaker effects on the viability of normal breast cells. MKI-1 clearly reduces both total c-Myc and serine 62-phosphorylation of c-Myc, with a decrease in ENSA phosphorylation[1].
In vivo	MKI-1 (50 mg/kg, ip, twice a week) enhances the radiosensitivity of the BT549 xenograft model to 6 Gy irradiation, reducing tumor growth without significant changes in body weight [1].
Synonyms	MASTL Kinase Inhibitor-1

Chemical Properties

Molecular Weight	302.33
Formula	C₁₈H₁₄N₄O
Cas No.	1190277-80-5
Smiles	O=C(Nc1nc2ccccc2[nH]1)c1cccc(c1)-n1cccc1

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 225 mg/mL (744.22 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.3076 mL	16.5382 mL	33.0764 mL	165.3822 mL
5 mM	0.6615 mL	3.3076 mL	6.6153 mL	33.0764 mL
10 mM	0.3308 mL	1.6538 mL	3.3076 mL	16.5382 mL
20 mM	0.1654 mL	0.8269 mL	1.6538 mL	8.2691 mL
50 mM	0.0662 mL	0.3308 mL	0.6615 mL	3.3076 mL
100 mM	0.0331 mL	0.1654 mL	0.3308 mL	1.6538 mL

Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc